We are excited to bring the conference coverage/highlights from the highly anticipated “2023 Precision Oncology Summit” that is taking place this weekend in the vibrant city of San Francisco. This important event
By Dr. Arya Mariam Roy of Roswell Park Comprehensive Cancer Center Development of endocrine resistance remains a challenge in the management of HR-positive HER2-negative breast cancer (HR+ HER2- BC). Alterations in PI3K
MoreBy Dr. Shipra Gandhi of Roswell Park Comprehensive Cancer Center Data from two phase III trials showed that adding immune checkpoint inhibition in the neoadjuvant setting in HR positive breast cancer was
MoreBy: BTF Staff October 28, 2023 – Known for its unwavering commitment to improving access to cancer care in resource-poor communities, the Binaytara Foundation hosted its “2023 Global Oncology Summit.” Central
MorePresented by: Pauline Funchain, M.D, Associate Professor of Medicine Stanford University, Stanford, CA. Covered by: Abdul Moiz Khan, M.D, Chief Fellow of Hematology and Oncology at Karmanos Cancer Institute, Detroit, MI.
MorePresented by: Ulka Vaishampayan, M.D., Professor of Medicine/GU Oncology at University of Michigan School of Medicine, Ann Arbor, MI. Covered by: Abdul Moiz Khan, M.D, Chief Fellow of Hematology and Oncology at
MorePresented by: Arlene Siefker-Radtke, M.D, Professor of Department of Genitourinary Medical Oncology at The University of Texas MD Anderson Cancer Center, Houston, TX. Covered by: Abdul Moiz Khan, M.D, Chief Fellow of
MorePresented by: Russell K Pachynski M.D, Associate Professor and Director of GU Oncology Research at The Division of Oncology, Siteman Cancer Center Washington University School of Medicine, St Louis, MO. Covered by:
MorePresented by: Joel W Neal, MD. PhD Covered by: Ivy Riano, M.D., Research Chief Fellow, Hematology and Oncology Unit, Dartmouth Cancer Center, Lebanon, NH. Dr. Joel Neal, Associate Professor of Medicine
MorePresented by: Millie Das, MD Covered by: Ivy Riano, M.D., Research Chief Fellow, Hematology and Oncology Unit, Dartmouth Cancer Center, Lebanon, NH. Dr. Millie Das, Chief of Oncology at the Palo
MorePresented by: Alex A. Adjei, MD, PhD, FACP Covered by: Ivy Riano, M.D., Research Chief Fellow, Hematology and Oncology Unit, Dartmouth Cancer Center, Lebanon, NH. Dr. Alex A. Adjei, chair of
More